Investor Ideas Unveils Tech and Defense Stocks to Track; (NASDAQ: $BENF), (TSX: $ILLM.TO), (NASDAQ: $AIFF), (Nasdaq: $ULY), (Nasdaq: $BNAI), (TSX: $MDA.TO), (TSXV: $CMI.V), (CBOE Canada: $MAXQ.NE)

Investor Ideas Unveils Tech and Defense Stocks to Track; (NASDAQ: $BENF), (TSX: $ILLM.TO), (NASDAQ: $AIFF), (Nasdaq: $ULY), (Nasdaq: $BNAI), (TSX: $MDA.TO), (TSXV: $CMI.V), (CBOE Canada: $MAXQ.NE)

 

 

March 14, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Tech and Defense sectors.

 

The newest tech companies are involved in AI (artificial intelligence), fintech and digital media.

 

The latest defense stocks are all involved in the satellite sector of defense/aerospace.

 

New stocks added today: Beneficient (NASDAQ: BENF), illumin Holdings Inc. (TSX: ILLM), Firefly Neuroscience, Inc. (NASDAQ: AIFF), Urgent.ly Inc. (Nasdaq: ULY), Brand Engagement Network, Inc. (Nasdaq: BNAI), MDA Space Ltd. (TSX:MDA.TO), C-Com Satellite Systems Inc. (TSXV: CMI), Maritime Launch Services (CBOE Canada: MAXQ).

 

Read this in full at https://www.investorideas.com/news/2025/main/03141Stocks.asp

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Tech Directories:

Beneficient (NASDAQ: BENF) – Ben, for short – is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors − mid-to-high net worth individuals, small-to-midsized institutions and General Partners seeking exit options, anchor commitments and valued-added services for their funds− with solutions that could help them unlock the value in their alternative assets. Ben’s AltQuote® tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess® portal to explore opportunities and receive proposals in a secure online environment.        

 

illumin Holdings Inc. (TSX: ILLM) is evolving the digital advertising landscape by empowering marketers to achieve transformative results through its customer-centric approach. Featuring a unified canvas built around the open web, illumin lets brands and agencies seamlessly plan, build, and execute campaigns across the entire marketing funnel—connecting programmatic channels, email, and social media within a single platform. Headquartered in Toronto, Canada, illumin serves clients across North America, Latin America, and Europe.

 

Firefly Neuroscience, Inc. (NASDAQ: AIFF) is an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, secured patent protection, and achieved FDA clearance. The Company is now launching BNA™ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use. Brain Network Analytics was developed using artificial intelligence and machine learning on Firefly’s extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. BNA™, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function. These insights can enhance a clinician’s ability to accurately diagnose mental and cognitive disorders and to evaluate what therapy and/or drug is best suited to optimize a patient’s outcome.

 

Urgent.ly Inc. (Nasdaq: ULY) is focused on helping everyone move safely, without disruption, by safeguarding drivers, promptly assisting their journey, and employing technology to proactively avert possible issues. The company’s digitally native software platform combines location-based services, real-time data, AI and machine-to-machine communication to power roadside assistance solutions for leading brands across automotive, insurance, telematics and other transportation-focused verticals. Urgently fulfills the demand for connected roadside assistance services, enabling its partners to deliver exceptional user experiences that drive high customer satisfaction and loyalty, by delivering innovative, transparent and exceptional connected mobility assistance experiences on a global scale.

 

Brand Engagement Network, Inc. (Nasdaq: BNAI) is a global leader in AI-powered customer engagement solutions. Headquartered in Jackson, Wyoming, with offices in Seoul, South Korea, BEN delivers advanced technology to enhance data utilization, improve interactions, and drive operational efficiency. BEN provides a secure, scalable AI platform that empowers businesses to build trust and achieve impactful results. Serving industries such as automotive, healthcare, and customer service, BEN uses AI-powered digital agents and advanced tools to streamline operations and enhance experiences. Its validated data is delivered through SaaS, Private Cloud, and On-Premises technology, ensuring data privacy and security while enabling efficient operations.

 

New Stocks Added to the Defense Directories:

MDA Space Ltd. (TSX:MDA.TO) is a trusted mission partner to the global space industry. A robotics, satellite systems and geointelligence pioneer with a 55-year+ story of world firsts and more than 450 missions, MDA Space is a global leader in communications satellites, Earth and space observation, and space exploration and infrastructure. The MDA Space team of more than 3,000 space experts in Canada, the US and the UK has the knowledge and know-how to turn an audacious customer vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there.

 

C-Com Satellite Systems Inc. (TSXV: CMI) is a pioneer and a leading global designer, developer, and manufacturer of transportable and mobile satellite-based antenna systems. The Company has developed proprietary, auto-acquisition controller technology for rapid antenna pointing to a satellite with just the press of a button, enabling Broadband Internet via Satellite across a wide range of market applications worldwide, including regions unserved or underserved by terrestrial access technologies. C-COM has sold more than 11,000 antenna systems, in over 100 countries, through a dedicated dealer network that provides service to a wide range of vertical markets such as Oil & Gas Exploration, Military Communications, Disaster Management, SNG, Emergency Communications, Cellular Backhaul, Telemedicine, Mobile Education, Government Services, Mobile Banking, and others. The Company's iNetVu® brand is synonymous with high quality, reliability, and cost-effectiveness. C-COM is in final stages of satellite testing and manufacturing of a potentially revolutionary Ka-band, electronically steerable, modular, conformal, flat panel phased array antenna. C-COM has developed this unique multi-orbit antenna with the intent of providing low-cost, high-throughput mobility applications over satellite for land, airborne and maritime verticals over LEO, MEO and GEO satellite constellations. Another significant project underway at C-COM is the development of an Analog Beamforming Integrated Circuit, which is progressing well and is expected to enter testing phase by the middle of this year. These BFICs will be used in the manufacturing of all of our ESA antennas with the intent to significantly reduce their cost and improve their performance.

 

Maritime Launch Services (CBOE Canada: MAXQ) is a Canadian-owned commercial space company based in Nova Scotia. Maritime Launch is developing Spaceport Nova Scotia, a launch site that will provide satellite delivery services to clients in support of the growing commercial space transportation industry over a wide range of inclinations. Spaceport Nova Scotia will allow launch vehicles to place their satellites into low-earth orbit. Spaceport Nova Scotia is Canada’s first commercial orbital launch complex.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 

 

 

 

 

 

 

 

 

 

 

Investorideas.com updates News Publishing and Digital Advertising Services

 

 

 

 

Investorideas.com updates News Publishing and Digital Advertising Services

 

 

March 11, 2025 – (Investorideas.com Newswire) Investorideas.com, recently named as a top 100 investment website by Feedspot’s panelist, updates services and prices for its press release and guest post/ digital advertising services.     Mining stocks, tech stocks. cleantech and other leading sectors can publish their news and be in front of thousands of investors, traders, and decision-makers with Investorideas.com, a trusted leader in finance, tech, and niche sector news for 25 plus years.   With current volatility in the markets and companies cutting spending, the newswire service has lowered costs accordingly with press release services starting at $149, https://www.investorideas.com/News-Upload/   Guest posts can be featured in leading sectors including biotech, gaming, crypto, sports or in our trading /finance content. As a leader in financial content creation, Investorideas can also write original content for your brand.  Prices for publishing start at $100. https://www.investorideas.com/Advertise/   Investorideas.com follows the money for investors as sector sentiment shifts and technology disrupts. Our mission is to help find great investor ideas with breaking news, articles, daily podcasts and interviews with leading experts.   Read this in full at https://www.investorideas.com/news/2025/main/03112News-Publishing-and-Digital-Advertising-Services.asp

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

 

Disclaimer/Disclosure: disclaimer and disclosure info https://www.investorideas.com/About/Disclaimer.asp

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, IR, PR and social media, podcasts and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about digital advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on X @investorideas @stocknewsbites

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Contact Investorideas.com

800 665 0411

 

 

 

 

 

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

 

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

 

Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology

 

Results Support Further Evaluation of the Hemopurifier® as Part of a Machine Perfusion Circuit to Further Assess its Impact on the Function of Retrieved Kidneys

 

SAN DIEGO, CA - March 10, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases and for use in organ transplantation, today announced the publication of a pre-clinical study in the peer-reviewed journal Transplant Immunology (https://doi.org/10.1016/j.trim.2025.102215) on February 28, 2025, entitled, "A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys."

 

Aethlon Medical's Hemopurifier® is a therapeutic blood filtration system designed to bind and remove harmful extracellular vesicles and life-threatening viruses from blood and other biological fluids. Its capabilities have potential applications in oncology and infectious diseases, and organ transplantation.

 

Paid News Dissemination of behalf of AEMD.

 

Read this in full at https://www.investorideas.com/news/2025/03101AEMD-Preclinical-Data-on-Hemopurifier-in-Transplant-Immunology-Journal.asp

 

"Kidney transplantation provides the highest quality of life for those afflicted with end stage renal disease, yet there is a shortage of organs available, and for those who do receive organs, complications may include delayed function and organ rejection," stated Steven LaRosa, MD, Senior Author of the publication and Chief Medical Officer of Aethlon Medical.

 

"The use of machine perfusion of recovered organs as opposed to cold storage has helped but there is still room for improvement. The release of extracellular vesicles (EVs) and microRNAs from the donor kidney are hypothesized to play a role in these complications.

With that in mind, we specifically examined the ability of the Hemopurifier to remove EVs and noxious microRNAs from the perfusion fluid from discarded kidneys that had undergone Controlled Oxygenated Rewarming. We demonstrated significant reductions in EVs as well as microRNAs implicated in renal dysfunction."

 

"While the company's funding and focus are dedicated to the Australian and India Oncology trials, the data generated from this pre-clinical study demonstrates that extracellular vesicle removal as a therapeutic target for the Hemopurifier extends beyond virology and oncology. We believe there exists a "pipeline within a device"," added James Frakes, Chief Executive Officer and Chief Financial Officer of Aethlon Medical. However, we acknowledge that further evaluation is needed, including incorporating the Hemopurifier into a machine perfusion circuit with discarded kidneys followed by a clinical trial. Our technology could be potentially "bolted on" to existing organ preservation technology.

 

About Aethlon and the Hemopurifier®

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," "potentially" or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such differences include, without limitation, the Company's ability to raise additional capital and to successfully complete development of the Hemopurifier; the Company's ability to successfully demonstrate the utility of the Hemopurifier in removing EVs and microRNAs from renal perfusates; the Company's ability to conduct its planned oncology clinical trials in Australia and India; the Company's ability to manage and successfully complete its current and future clinical trials, if initiated; the Company's ability to conduct clinical trial(s) designed to demonstrate benefits of the incorporation of the Hemopurifier® into renal perfusion; the Company's ability to successfully manufacture the Hemopurifier in sufficient quantities for its clinical trials, and other potential risks. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2024, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances

.

Additional information can be found at www.AethlonMedical.com.

 

Company Contact:
Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

 

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com

 

SOURCE Aethlon Medical, Inc.

 

Aethlon Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com

 

More info on AEMD at Investorideas.com Visit: 

https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Athelon Medical, Inc. (AEMD) is a paid featured  medical tech stock on Investor ideas  More disclosure:Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

 

 

Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories

 

nvestorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports; (Nasdaq: $AARD), (NASDAQ: $SION), (Nasdaq: $NNNN), (NASDAQ: $CJMB), (NASDAQ: $XHLD), (NASDAQ: $ODYS), (NYSE: $TTAM), (NASDAQ: $FBGL), (NYSE: $KRMN), (NASDAQ: $AGH)

Investorideas.com adds New IPOs in Biotech, Technology, Homebuilder, Aerospace, Sports; (Nasdaq: $AARD), (NASDAQ: $SION), (Nasdaq: $NNNN), (NASDAQ: $CJMB), (NASDAQ: $XHLD), (NASDAQ: $ODYS), (NYSE: $TTAM), (NASDAQ: $FBGL), (NYSE: $KRMN), (NASDAQ: $AGH)  

 

 

 

March 7, 2025 – (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces today’s IPO’s  to watch in the Biotech, Technology, Homebuilder, Aerospace and Sporting sectors.

 

New companies are all Nasdaq/NYSE IPOs from February 2025.

 

New stocks added today: Aardvark Therapeutics, Inc. (Nasdaq:AARD), Sionna Therapeutics, Inc. (NASDAQ:SION), Anbio Biotechnology (Nasdaq:NNNN), CALLAN JMB INC. (NASDAQ:CJMB), TEN Holdings, Inc. (NASDAQ:XHLD), Odysight.ai Inc. (NASDAQ:ODYS), Titan America SA (NYSE:TTAM), FBS Global Ltd  (NASDAQ:FBGL), Karman Holdings Inc. (NYSE:KRMN), Aureus Greenway Holdings Inc (NASDAQ:AGH).

 

Read this in full at https://www.investorideas.com/news/2025/main/03071Stocks.asp

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Biotech Directories:

Aardvark Therapeutics, Inc. (Nasdaq:AARD) is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its portfolio of small molecule programs targets biological pathways associated with alleviating hunger. Aardvark’s lead product candidate, ARD-101, targets Bitter Taste Receptors (TAS2Rs) expressed in the gut lumen, inducing secretion of endogenous signaling molecules, including the satiety hormone cholecystokinin (CCK), which in turn activates gut-brain signals to suppress the sensation of hunger. This potential first-in-class oral investigational drug demonstrated clinical activity and was well-tolerated in Phase 2 trials and has entered Phase 3 development for hyperphagia associated with Prader-Willi Syndrome, for which Aardvark has been granted Orphan Drug Designation. Additionally, Aardvark intends to advance ARD-101 into Phase 2 development for hyperphagia associated with hypothalamic obesity, with a goal of addressing significant unmet needs across both these rare disease indications. Aardvark is also developing ARD-201, which will be a fixed-dose combination of ARD-101 with a dipeptidyl peptidase-4 (DPP-4) inhibitor, with a goal of addressing some of the limitations of currently marketed GLP-1 therapies for the treatment of obesity and obesity-related conditions.

 

Sionna Therapeutics, Inc. (NASDAQ:SION) is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the CFTR protein. Sionna’s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR’s nucleotide-binding domain 1 (NBD1), which the company believes is central to potentially unlocking dramatic improvements in clinical outcomes and quality of life for people with CF. Leveraging more than a decade of the co-founders’ research on NBD1, the company is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in NBD1. Sionna is also developing a portfolio of complementary CFTR modulators that are designed to work synergistically with its NBD1 stabilizers to improve CFTR function.

 

Anbio Biotechnology (Nasdaq:NNNN) is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. It is an innovation-driven global diagnostic company offering a diverse portfolio of mature diagnostic assays and five key platforms for biomarker detection, including Fluorescent Immunochromatographic Solution (FIA), Chemiluminescent Immunoassay Solution (ChLIA), Polymerase Chain Reaction Solution (PCR), Lateral Flow Assay Solution (LFIA), and Loop-Mediated Isothermal Amplification Solution (LAMP). These solutions cater to point-of-care settings, laboratory, and over-the-counter applications, enabling healthcare providers and patients to access fast, reliable, and cost-effective diagnostic tools. With a strong global presence across the EU, APAC, and the Americas, the Company’s Conformité Européenne (CE)-marked products detect biomarkers associated with critical medical domains, encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Designed for compatibility with multiple sample collection matrices, including serum, plasma, whole blood, feces, urine, and saliva, the product lineup facilitates efficient and reliable diagnostic testing across diverse patient populations and healthcare settings. By prioritizing innovation, affordability, and speed, Anbio aims to transform the global diagnostics landscape, fostering a paradigm shift towards personalized and decentralized diagnostic solutions.

 

CALLAN JMB INC. (NASDAQ:CJMB) is an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. Our combined expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our specialty packaging.

 

New Stocks Added to the Tech Directories:

TEN Holdings, Inc. (NASDAQ:XHLD) is a provider of event planning, production, and broadcasting services headquartered in Pennsylvania. The Company mainly produces virtual and hybrid events and physical events. Virtual and hybrid events involve virtual and hybrid event planning, production and broadcasting services, and continuing education services, all of which are supported by the Company's proprietary Xyvid Pro Platform. Physical events mainly involve live streaming and video recording of physical events.

 

Odysight.ai Inc. (NASDAQ:ODYS) is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded software, and AI algorithms are being deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases. Odysight.ai’s platform allows maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring.

 

New Stocks Added to the Homebuilder Directories:

Titan America SA (NYSE:TTAM) is a leading vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating primarily on the Eastern Seaboard of the United States. As a leading provider of materials that contribute to lower carbon emissions compared to traditional building materials, Titan America serves markets that benefit from population growth, economic growth, and technology and innovation trends that are among the strongest in the United States.

 

FBS Global Ltd  (NASDAQ:FBGL) provides construction and engineering services in Singapore. It undertakes interior fit-out works for institutional, residential, commercial, and industrial building projects. The company also supplies building materials and precast concrete components; recycles construction and industrial wastes; and offers pavement consultancy services.

 

New Stocks Added to the Aerospace Directories:

Karman Holdings Inc. (NYSE:KRMN) specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense and space sector initiatives

 

New Stocks Added to the Sporting Directories:

Aureus Greenway Holdings Inc (NASDAQ:AGH) owns and operates daily fee golf country clubs in the state of Florida that are designed to appeal to a wide-ranging population. The combination of our strategic locations and approachable golf-courses attracts both local and tourist demographics, allowing us to offer a variety of golf experiences while capturing a broad share of discretionary leisure spending. 

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 

New Defense Stock Coming to Market-VisionWave Technologies Merger with Bannix Acquisition (NASDAQ: $BNIX)

 

New Defense Stock Coming to Market-VisionWave Technologies Merger with Bannix Acquisition (NASDAQ: $BNIX)  

 

Stocks Mentioned: (NASDAQ: $BNIX) (NYSE: $LMT) (NYSE: $GD), (NYSE: $LHX) (NYSE: $NOC)  

 

 

 

 

 

March 6, 2025 -   Investorideas.com, a top 100 investment site for 2025, releases a snapshot on defense stocks as global spending increases, and a new era of security emerges.    

 

According to the International Institute for Strategic Studies, “in 2024, global defense spending reflected intensifying security challenges and reached USD2.46 trillion, up from USD2.24trn the previous year.”

 

As President Trump calls for changes in defense spending, the world is adapting to the new reality that each country needs to build and expand on its own defense budget.

 

Shares of the top defense companies like Lockheed Martin (NYSE:LMT) General Dynamics (NYSE:GD), L3Harris Technologies (NYSE:LHX) and Northrop Grumman Corporation (NYSE:NOC) have stabilized after reaction to proposed defense cuts  and have since seen gains following the recent Trump-Zelenskyy meeting.

 

As defense budgets surge in Germany, France and other countries, some of top European defense stocks saw gains of up to 40% as investors traded on the sentiment of headlines.

 

In US markets, there is a new emerging defense technology company looking to go public.  Bannix Acquisition Corp. (NASDAQ: BNIX) recently filed an amended S-4 registration statement, with details of its target, VisionWave Technologies, Inc., coming into sharper focus. The filing outlines VisionWave’s business model, proprietary technology and commercialization strategy, providing insight into a company poised to revolutionize defense and security through AI-powered autonomous systems, radar technology, and advanced sensing solutions.

 

This news is paid news dissemination for Bannix Acquisition Corp.

 

Read this news, featuring BNIX in full at https://www.investorideas.com/news/2025/defense/03061VisionWave-Technologies.asp

 

VisionWave Technologies is an emerging defense technology company specializing in AI-driven solutions for military, homeland security and industrial applications. The company’s strategy is three-pronged:

 

          1.       Technology Licensing – VisionWave intends to license its proprietary AI and sensor technology to defense contractors and government agencies, enabling integration into existing military and security systems.

          2.       Direct Product Sales – The Company will manufacture and sell unmanned vehicles, remote weapon stations, and advanced radar systems directly to military, law enforcement, and industrial clients.

          3.       Strategic Partnerships – VisionWave is actively pursuing alliances and joint ventures with industry leaders to co-develop customized solutions based on its proprietary technology.

 

The company is transitioning from research and development (R&D) to full commercialization, with several pilot projects already underway.

 

VisionWave’s proprietary technology portfolio is built on AI-driven defense innovations, with key developments including:

 

1. Event-Based AI Vision Technology:

 

Inspired by biological vision systems, this AI-driven sensor technology allows real-time tracking of fast-moving or stealth objects, such as:

   •   Drones

   •   Mortars and rockets

   •   Bullets in mid-air

 

Unlike traditional thermal imaging, VisionWave’s event-based vision sensors process pixel-level changes, functioning like an AI-powered optical radar.

 

2. CoPilot AI: Fully Autonomous Drone Technology:

 

VisionWave’s CoPilot AI enables drones to operate autonomously, including:

   •   Intercepting incoming drones

   •   Executing swarm formations

   •   Adapting to mission requirements in real-time

 

This “fire-and-forget” AI-driven system outperforms human pilots in complex military and security scenarios.

 

3. Vision-RF: AI-Powered Radio Frequency Imaging:

 

One of VisionWave’s most groundbreaking innovations, Vision-RF can convert radio frequency (RF) signals into real-time images, allowing for:

   •   Aerial threat detection

   •   Through-wall visualization

   •   Underground activity monitoring

 

This technology is protected by multiple patents and has significant potential applications in defense, law enforcement, and infrastructure monitoring.

 

4. Remote Weapon Stations (RWS):

 

VisionWave has developed an advanced remote weapon system for combat vehicles and naval applications. This system:

   •   Enhances precision targeting

   •   Provides stabilization for better accuracy

   •   Integrates seamlessly into existing defense platforms

 

The company has already begun production in partnership with a U.S. military contractor, with full-scale manufacturing expected in 2025.

 

5. AI-Enabled Tactical Platforms:

 

VisionWave’s micro-ATV platform is designed for:

   •   Stealthy, high-mobility operations

   •   Law enforcement and Special Forces

   •   Medical evacuation and rapid response

 

This four-wheel-drive electric vehicle offers silent maneuverability, providing an edge over traditional gas-powered military transport.

 

VisionWave is at a critical inflection point, moving from prototype development to commercialization. The company has eight product lines, with several already at Technology Readiness Level (TRL) 7 or higher, meaning they are proven in operational environments.

 

Pilot projects with defense and homeland security agencies are actively being conducted and the company anticipates full-scale commercial production in 2025.

 

VisionWave faces competition from major defense contractors like Lockheed Martin, Northrop Grumman and Raytheon, as well as specialized drone defense firms such as Dedrone and Anduril Industries. However, the company’s proprietary AI-driven approach and patented technologies hopes to provide a strong competitive advantage.

 

Following a successful merger with Bannix Acquisition Corp, VisionWave will become a publicly traded company on NASDAQ under the ticker symbols:  VWAV (common stock) and

VWAVW (warrants).

 

VisionWave Technologies is positioning to be a next-generation defense technology firm with a strong focus on AI-driven military and security solutions. With proprietary radar, vision and autonomous technology, the company plans to disrupt traditional defense markets.

 

Commenting on the current state of the current evolving defense market, CEO of global financial advisory giant deVere Group opines,“ Almost every investor needs exposure to defense stocks amid shifting geopolitical realities.”

 

The comments from Nigel Green come as the Stoxx Europe aerospace and defence index has skyrocketed, as investors reposition for what is now an undeniable reality: defence spending is set to climb for years to come.

 

He says: "With European leaders scrambling to reinforce their military capabilities after the US distanced itself from security commitments, defense companies stand to be major beneficiaries.

 

"We believe that this is likely to be the beginning of a fundamental realignment that will shape markets for the foreseeable future.

 

"The shift is structural. Governments across Europe are coming to terms with the fact that their decades-long reliance on US military backing can no longer be taken for granted.

 

"The Trump administration's refusal to provide clear security guarantees has made it clear that Europe must shoulder more of the burden itself. This will translate into significant, sustained increases in defense budgets.

 

"From Asia to the Middle East, the pattern is clear: countries are prioritizing security and resilience, and the defense sector is the primary beneficiary," notes the deVere Group CEO.

 

According to a recent article quoting US defense analyst Shaun McDougall talking about Trumps’ proposed cuts, “He wants the military to focus solely on its warfighting capabilities, so the administration has begun eliminating efforts like diversity programs that he doesn’t think contribute to that warfighting mentality.”

 

Continued: “Trump’s Republican Party is actively working to increase the defense budget right now. Several key Republican lawmakers who oversee defense committees in Congress argue that the US should be raising its defense budget to at least $1 trillion. It would be hard for Trump to convince them to go the opposite direction and reduce spending by such a large amount.”

 

Behind the knee-jerk market reaction to Trump’s  news, it’s business as usual for the big defense contractors, as on January 31^st, the US Navy awarded Lockheed Martin (NYSE: LMT) a $383 million cost-plus-incentive-fee and cost-plus-fixed-fee modification to the existing Lockheed Martin contract for development of the next generation of the Trident II Strategic Weapons System (SWS) D5 missile to continue the nation's sea-based strategic deterrence.

 

For investors following defense stocks- follow the money it will tell the real story. 

 

Research aerospace and defense stocks at Investorideas.com

https://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

 

Disclaimer/Disclosure: Disclosure: this news article featuring BNIX/VisionWave is paid for content creation   on Investorideas.com (one thousand eight hundred) .Our site does not make recommendations for purchases or sale of stocks, services or products.  This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This is not investment opinion .All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 

Get more Defense Stock Investor Ideas - news, articles, and stock directories